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Hearts deficient in both Mfn1 and Mfn2 are protected
against acute myocardial infarction
AR Hall1, N Burke1, RK Dongworth1, SB Kalkhoran1, A Dyson2, JM Vicencio1, GW Dorn II3, DM Yellon1 and DJ Hausenloy*,1,4,5
Mitochondria alter their shape by undergoing cycles of fusion and fission. Changes in mitochondrial morphology impact on the
cellular response to stress, and their interactions with other organelles such as the sarcoplasmic reticulum (SR). Inhibiting
mitochondrial fission can protect the heart against acute ischemia/reperfusion (I/R) injury. However, the role of the mitochondrial
fusion proteins, Mfn1 and Mfn2, in the response of the adult heart to acute I/R injury is not clear, and is investigated in this study. To
determine the effect of combined Mfn1/Mfn2 ablation on the susceptibility to acute myocardial I/R injury, cardiac-specific ablation
of both Mfn1 and Mfn2 (DKO) was initiated in mice aged 4–6 weeks, leading to knockout of both these proteins in 8–10-week-old
animals. This resulted in fragmented mitochondria (electron microscopy), decreased mitochondrial respiratory function
(respirometry), and impaired myocardial contractile function (echocardiography). In DKO mice subjected to in vivo regional
myocardial ischemia (30 min) followed by 24 h reperfusion, myocardial infarct size (IS, expressed as a % of the area-at-risk) was
reduced by 46% compared with wild-type (WT) hearts. In addition, mitochondria from DKO animals had decreased MPTP opening
susceptibility (assessed by Ca2+-induced mitochondrial swelling), compared with WT hearts. Mfn2 is a key mediator of
mitochondrial/SR tethering, and accordingly, the loss of Mfn2 in DKO hearts reduced the number of interactions measured
between these organelles (quantified by proximal ligation assay), attenuated mitochondrial calcium overload (Rhod2 confocal
microscopy), and decreased reactive oxygen species production (DCF confocal microscopy) in response to acute I/R injury. No
differences in isolated mitochondrial ROS emissions (Amplex Red) were detected in response to Ca2+ and Antimycin A, further
implicating disruption of mitochondria/SR tethering as the protective mechanism. In summary, despite apparent mitochondrial
dysfunction, hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction due to impaired
mitochondria/SR tethering.
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New therapeutic strategies are required to protect the heart
against acute ischemia/reperfusion (I/R) injury in patients
with ischemic heart disease, the leading cause of death
and disability worldwide. Acute myocardial I/R injury causes
cardiomyocyte death by inducing mitochondrial Ca2+ over-
load, the production of mitochondrial oxidative stress, and
the opening of the mitochondrial permeability transition pore
(MPTP).1–3 Therefore, preventing these detrimental effects of
acute myocardial I/R injury on mitochondrial function is an
important therapeutic strategy for cardioprotection.
Mitochondria undergo continual cycles of fusion and
fission, processes which are fundamental to mitochondrial
health – a phenomenon that has been termed ‘mitochondrial
dynamics’.4–8 Mitochondrial quality is maintained by mito-
chondrial fusion, which allows mixing of mitochondrial DNA,
lipids, proteins, and metabolites, and mitochondrial fission,
which allows the selective removal of damaged mitochondria
by mitophagy.9 The key proteins mediating mitochondrial
fusion are the Mitofusins (Mfn1 and Mfn2)10 and optic atrophy
1 (OPA1),11 while dynamin related protein 1 (Drp1)12 mediates
mitochondrial fission by interacting with human fission protein
(hFis1),13 mitochondrial fission factor (MFF),14 and mitochon-
drial dynamics proteins of 49 and 51 kDa (MiD49/MiD51).15
Mfn2 has a number of pleioptropic non-fusion effects including
acting as a tether betweenmitochondria and the sarcoplasmic
reticulum (SR).16
An optimal mitochondrial/SR tethering is essential for Ca2+
transfer from the SR to mitochondria and for maintaining
cardiac bioenergetics. The dissociation of these organelles in
murine hearts deficient in Mfn2 profoundly reduced Ca2+
transfer from the SR to the mitochondria. The uncoupling of
mitochondrial ATP production from the energy requirements
required by cardiac contraction17 has been shown to result in
an overt hypertrophic phenotype, coupled with alterations in
autophagy and ROS signaling.18
During I/R, mitochondria have been demonstrated to
undergo Drp1-dependent fission in response to acute I/R
injury. Accordingly, genetic or pharmacological inhibition of
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Drp1 has been reported to protect isolated cardiomyocytes
against simulated I/R injury19 and reducemyocardial IS in both
adult murine and rat hearts.19–22 The role of the Mitofusins,
Mfn1 and Mfn2, in the setting of acute myocardial I/R injury is
not so clear. Therefore, in the current study, we investigated
the acute effects of cardiac-specific ablation of both Mfn1 and
Mfn2 on the susceptibility of the heart to acute I/R injury.
Results
Genetic knockout of Mfn1 and Mfn2. Utilizing the MerCre-
Mer inducible cardiac-specific knockout model, both Mfn1
and Mfn2 were genetically ablated in the adult murine
cardiomyocytes by administration of tamoxifen in 4–6-week-
old mice. Western blotting confirmed the ablation of both
Mfn1 and Mfn2 between 8 and 10 weeks of age, the age at
which all further experiments were conducted. There were no
compensatory changes in protein expression of cardiac OPA1
or Drp1 in DKO compared with WT hearts (Figure 1a).
Abnormal mitochondrial morphology in hearts deficient
in both Mfn1 and Mfn2. Electron microscopy of hearts
deficient in both Mfn1 and Mfn2 revealed predominantly
fragmented interfibrillar mitochondria (smaller and reticular in
shape) with loss of cristae structure when compared with WT
hearts (Figures 1b and c).
Hearts deficient in both Mfn1 and Mfn2 are protected
against acute I/R injury. Hearts deficient in both Mfn1 and
Mfn2 had no evidence of cardiomyopathy at 8–10 weeks, with
normal left ventricular chamber dimensions and no evidence
of left ventricular hypertrophy (normal heart weight/body ratio;
Supplementary Figure 1a). Following in vivo acute myocardial
I/R injury, the IS to area-at-risk ratio (IS/AAR%) was
significantly reduced from 41±3.6% to 22± 3.7% in DKO
mice compared with WT littermates (Figures 1d and e). There
was no difference in the size of the AAR (Supplementary
Figure 1b).
Impaired contractile function in hearts deficient in both
Mfn1 and Mfn2. DKO mice had evidence of impaired
myocardial contractile function under basal conditions and
in response to isoproterenol (ISO) stress with reduced aortic
velocity (Figure 2b), reduced stroke volume (Figure 2c), and
reduced cardiac output (Figure 2d) when compared with WT
mice. However, heart rate (Figure 2a), fractional shortening,
and both posterior and anterior wall thickness during both
systole and diastole were unaffected when compared with
WT hearts (Supplementary Figures 2a–e).
Figure 1 Acute ablation of both cardiac Mfn1 and Mfn2 altered mitochondrial morphology and protected the heart against acute myocardial infarction. (a) Western blotting
confirmed the absence of both Mfn1 and Mfn2 in double knockout (DKO) hearts when compared with wild-type (WT) hearts with no significant difference in OPA1 or Drp1 protein
levels (representative images). Representative quantifications are shown below the individual blots. (b) Electron microscopy shows changes in mitochondrial morphology in DKO
hearts when compared with WT hearts, with fragmented reticular mitochondria and altered cristae structure (representative images – scale bars at 2 and 0.2 μm, respectively).
(c) Interfibrillar mitochondrial area is significantly reduced in DKO hearts compared with WT interfibillar mitochondria using 2D EM analysis. N= 3 hearts/group with around 400
mitochondria analyzed per heart. Error bars indicate S.E.M. Nonparametric Mann–Whitney t-test. *P≤ 0.05. (d) Hearts deficient in both Mfn1 and Mfn2 (DKO) were resistant to
acute I/R injury as evidenced by a significant reduction in myocardial IS when compared with WT hearts, expressed as IS as a percentage of the area-at-risk (AAR). N= 6/group.
Error bars indicate S.E.M. Unpaired t-test. **P≤ 0.001. (e) Representative images of short-axis heart slices following dual staining with Evan’s blue and tetrazolium to stain the
AAR and areas of infarction, respectively
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Impaired mitochondrial respiratory capacity in hearts
deficient in both Mfn1 and Mfn2. To test whether
Mfn1/Mfn2 deficiency impacts upon mitochondrial oxygen
consumption, respiratory function was measured in both
isolated mitochondria and isolated intact cardiac ventricular
cardiomyocytes. ADP-stimulated mitochondrial respiration
(state 3) was significantly impaired in mitochondria isolated
from DKO cardiac tissue, when the functionality of complex I
and complex II was tested, compared with WT mitochondria
(Figures 3a and b). A trend towards a reduced maximal
respiration (FCCP stimulated) was observed in DKO com-
pared with WT mitochondria (Figures 3a and b). In addition, a
significant reduction in maximal respiration was observed in
DKO intact cardiomyocytes compared with WT (Figure 3c),
although this was not associated with a reduction in
expression of the respiratory complexes (Figure 3d).
Resistance to MPTP opening in cardiomyocytes deficient
in both Mfn1 and Mfn2. DKO cardiac mitochondria were
also found to be resistant to MPTP opening as evidenced
by less mitochondrial swelling in response to Ca2+ when
compared with WT mitochondria (Figure 3e). Ca2+-induced
mitochondrial swelling was prevented by the known MPTP
inhibitor, CsA, confirming that this experimental model was
assessing MPTP opening (Figure 3f).
Less mitochondrial Ca2+ overload during simulated I/R in
cardiomyocytes deficient in both Mfn1 and Mfn2 due to a
reduced mitochondria–SR interaction. With Mfn2 reported
to mediate tethering between the mitochondria and SR, we
hypothesized that Ca2+ transfer from the SR to mitochondria
would be decreased in DKO hearts and so there may be a
difference in mitochondrial Ca2+ handling during acute
I/R injury. First, we assessed the interaction between the
mitochondria and the SR in ventricular cardiomyocytes
isolated from WT and DKO using the proximal ligation assay
(interaction detection range 0–40 nm), targeting the SR Ca2+
channel RyR and the mitochondrial Ca2+ channel VDAC. The
degree of interaction was significantly reduced in DKO
cardiomyocytes when compared with WT cardiomyocytes,
using both two-dimensional and three-dimensional analyses
(Figures 4a-c). To control that the decreased interaction
between RyR and VDAC observed in the PLA data was not
an artifact due to a different expression of these proteins in
the DKO model, we performed conventional immunocyto-
chemistry experiments and western blotting. We validated
Figure 2 Knockout of Mfn1 and Mfn2 significantly reduced contractile power, stroke volume, and cardiac output without affecting heart rate. (a) Genetic knockout of Mfn1 and
Mfn2 did not alter heart rate at baseline or in response to adrenergic stimulation. (b) Peak blood flow through the aorta is reduced in DKOmice at baseline and under isoproterenol
(ISO) stimulation. (c) Cardiac stroke volume is reduced at baseline in DKO mice. (d) Cardiac output is reduced at baseline and under ISO stimulation in DKO mice.
(e) Representative Doppler traces of blood flow in the aorta in WT mice at baseline and 4 min post ISO administration (4 ng/g body weight). (f) Representative Doppler traces of
blood flow through the aorta in DKO mice at baseline and 4 min post ISO administration (4 ng/g body weight). N= 3/group, and statistical analysis was performed by a one-way
ANOVA with a Tukey post-test. *P≤ 0.05. Error bars indicate S.E.M.
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that their expression was comparable in WT and DKO cells
for both biochemical techniques (Figures 4d and e), and
importantly, that their subcellular distribution was also
maintained in the DKO cells. This validates the PLA result,
confirming that despite being present in a striated pattern,
which may suggest close physical localization, both
the RyR and VDAC require a molecular micro-domain to
interact, in which Mfn proteins are essential mediators. We
observed no significant differences in cytosolic Ca2+ between
WT and DKO cardiomyocytes at baseline or in response to
acute I/R injury to explain the observed differences in
mitochondrial Ca2+ loading (Figures 5a and b), suggesting
unaltered cytosolic Ca2+ handling in DKO hearts. However,
there was a significant increase in mitochondrial Ca2+ levels
during simulated ischemia in WT cardiomyocytes, which was
absent in DKO cells (Figures 5c and d). To confirm the
differences in mitochondrial Ca2+ transfer from the SR
observed between WT and DKO cells results, we adminis-
tered the SERCA inhibitor tert-butylhydroquinone (50μM,
tBHQ). In WT myocytes, a steady mitochondrial Ca2+ uptake
was observed as an increase in Rhod2 fluorescence, which
was delayed in DKO cells (Figures 5e and f). Together, these
results suggest an impaired mitochondrial Ca2+ uptake in the
DKO hearts.
Less oxidative stress production in cardiomyocytes
deficient in both Mfn1 and Mfn2. No differences in
oxidative stress between WT and DKO cardiomyocytes were
observed under baseline conditions. However, in response to
simulated ischemia, there was an increase in oxidative stress
in the WT cardiomyocytes, which was attenuated in DKO
cells (Figures 6a and b). During simulated reperfusion, there
was a similar difference in oxidative stress, with DKO
demonstrating a significant reduction compared with WT
cardiomyocytes. Importantly, the differences in mitochondrial
Ca2+ or ROS levels were not due to changes in mitochondrial
membrane potential as this did not differ between WT and
DKO cells (Figures 6c and d). To assess whether the
differences in ischemic oxidative stress were mediated by
changes in Ca2+ transfer due to mitochondria–SR tethering,
rather than due to Ca2+ uptake defects intrinsic to mitochon-
dria in the DKO hearts, H2O2 emissions were measured in
mitochondria isolated from WTand DKO hearts. The addition
of Ca2+ and Antimycin A (to simulate ischemic Ca2+ overload
and electron transfer chain inhibition) significantly increased
H2O2 production compared with baseline, although to the
same extent in WTand DKO mitochondria (Figures 7a and b).
No changes in mitochondrial calcium uniporter expression
(Figure 7c) (the principal pathway through which Ca2+ enters
the mitochondria) were observed. These data imply that the
reduced ROS generation observed in isolated DKO myocytes
(Figure 6c) was because of a reduced Ca2+ overload
resulting from the disassociation of the mitochondria from
the SR, and not to intrinsic Ca2+ uptake deficiencies in DKO
mitochondria.
Figure 3 Acute ablation of both cardiac Mfn1 and Mfn2 resulted in impaired mitochondrial respiratory function. (a) ADP-stimulated mitochondrial respiration in the presence
of complex I substrates (GMP – Glutamate, Malate, and Pyruvate) was impaired in DKO cardiac mitochondria compared with WT cardiac mitochondria. (b) ADP-stimulated
mitochondrial respiration in the presence of complex II substrate (Succinate) and the complex I inhibitor Rotenone was impaired in DKO cardiac mitochondria compared with WT
cardiac mitochondria. (c) The maximal oxygen consumption rate (due to uncoupling by FCCP) was decreased in isolated DKO ventricular cardiomyocytes compared with WTs.
N= 5 respiratory run per group, mitochondria were pooled from 15 mice of each genotype, and statistical analysis was performed by a two-way ANOVA. *Po0.05. Error bars
indicate S.E.M. (d) Expression of mitochondrial subunits is not significantly altered by dual KO of Mfn1 and Mfn2 at the timepoint studied. (e) Mitochondrial swelling induced by
600 μM CaCl2 is inhibited in DKO mitochondria when compared with WT mitochondria. (f) Mitochondrial swelling induced by 600 μM CaCl2 is inhibited the MPTP inhibitor
cyclosporin-A (CsA, 1 μM). N= 3 triplicate runs of mitochondria isolated from nine mice. Error bars indicate S.E.M. and statistical analysis was performed by analysis of the linear
regression. *Po0.05
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Discussion
We found that the acute ablation of both cardiac Mfn1 and
Mfn2 protected the heart against acute myocardial infarction.
This was despite abnormal mitochondrial morphology,
decreased mitochondrial respiratory function, and impaired
myocardial contractile function. As well as an intrinsic
resistance to MPTP opening, the cardioprotection was
associated with an attenuated mitochondrial Ca2+ overload
and oxidative stress in DKO cardiomyocytes subjected to
acute I/R injury as a result of a disrupted mitochondria–SR
tethering.
Although genetic or pharmacological inhibition of Drp1 has
been shown to inhibit ischemia-induced mitochondrial fission
and protect the heart against acute I/R injury,19–22 the
role of the Mitofusins in this setting is not so clear. In vitro,
using the HL-1 cardiac cell line, it has been shown that
the overexpression of either Mfn1 or Mfn2 attenuated cell
death induced by simulated I/R injury.19 In contrast, the siRNA
knockdown of Mfn2 worsened cell survival following simulated
I/R injury in neonatal rat cardiomyocytes.23 These findings
suggest that the Mitofusins may have a cardioprotective role in
cellular models of acute I/R injury. However, in the adult heart,
the cardiac-specific ablation of either Mfn1 or Mfn2 have
produced unexpected and contrasting results in terms of
cellular protection. Adult murine cardiomyocytes deficient in
Mfn1 have been shown to be resistant to both MPTP opening
and cell death induced by oxidative stress,24 and cardiomyo-
cytes isolated from Mfn2-deficient adult mice were found to be
resistant to MPTP opening and were protected against
simulated I/R injury.23 The reason for these discordant findings
is not clear, but it may relate to the pleiotropic actions of the
Mitofusin proteins.25 In this regard, Mfn2 has been shown
to be required to tether SR to mitochondria,16 which promotes
efficient Ca2+ transfer to sustain bioenergetic demands.
However, Mfn2 is also essential for mitochondrial fusion, and
its absence promotes a fragmented mitochondrial network,
which would be intrinsically less resistant to I/R injury. Other
reported functions of Mfn2 are to mediate autophagy by
facilitating the fusion of autophagosomes with lysosomes,26
and its absence promotes accumulation of damaged mito-
chondria, which are also more susceptible to damage. On the
basis of these different functions of Mfn2, the question arises
as to which of these functions is more important in an acute
setting of damage such as I/R injury.
In our study, we investigated the acute effect of ablating the
Mitofusins on the susceptibility of the heart to acute I/R injury.
We found that hearts deficient in both Mfn1 and Mfn2 were
resistant to acute myocardial infarction, and that this cardio-
protective phenotype was due to beneficial effects on
mitochondrial Ca2+ levels, oxidative stress, and MPTP open-
ing – key mediators of cardiomyocyte death in the setting of
Figure 4 Acute ablation of both cardiac Mfn1 and Mfn2 reduces the interaction between the mitochondria and SR. (a) 2D confocal images showing the points of interaction
between mitochondria and the SR in myocytes isolated fromWTand DKO hearts, as visualized by the red dots, the nucleus is visualized in blue. Magnified insets show the zone of
a line-scan fluorescence profile analysis (white arrow), plotted in the right. (b) Whole-cell 3D rendering from multiple z-stack images, compiling the points of interaction between
the mitochondria and the SR in myocytes isolated from WT and DKO hearts, as visualized in gold, with the nucleus visualized in blue. (c) Quantification of the whole-cell 3D
interactions visualized between the mitochondria and the SR. Antibodies to VDAC and the ryanodine receptor (Pan-RyR) were used as to mark the mitochondria and SR,
respectively, prior to the proximal ligation assay. N= 80 cells from three heart isolations. Error bars indicate S.E.M. and statistical analysis was performed by an unpaired t-test.
*P≤ 0.05. (d) Representative immunocytochemistry images of myocytes isolated from WT and DKO hearts stained with antibodies for VDAC (green) and Pan-RyR (red).
(e) Representative western blot image of VDAC and RyR expression in whole heart homogenate taken from WT and DKO mice
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acute I/R injury. Our data suggested that acute ablation of
cardiac Mfn1 and Mfn2 attenuated mitochondrial Ca2+
accumulation and decreased oxidative stress production
during acute I/R injury. Despite the hypothetical susceptibility
of fragmented mitochondria to stress, our findings in which we
observed decreased ER-mitochondrial contact demonstrate
that this function is critical for the protection against I/R injury in
the DKO hearts.
Mitochondrial uptake of Ca2+ via the mitochondrial calcium
uniporter from the SR in response to acute I/R injury induces
MPTP opening at the onset of reperfusion and is a major
determinant of cardiomyocyte death.27 Preventing mitochon-
drial Ca2+ overload during acute I/R injury has been shown to
attenuate cardiomyocyte death and reduce myocardial
IS.28–30 In our study, we found that the increase in mitochon-
drial uptake of Ca2+ induced by acute I/R injury was absent in
hearts deficient in both Mfn1 and Mfn2 and the potential
mechanism for this is discussed in the following section.
Owing to the low affinity of the mitochondrial calcium
uniporter for Ca2+, the transfer of Ca2+ from the SR to
mitochondria requires these two organelles to be closely
juxtaposed, as this allows the formation of subcellular micro-
domains of high Ca2+ concentration.16,17 This spatial relation-
ship between SR and mitochondria is required to couple the
energy demands of excitation–contraction with mitochondrial
ATP production. In this regard, Mfn2 has been shown to act
as a tether between the SR and mitochondria, and hearts
deficient in Mfn2 have been demonstrated to develop a
chronic cardiomyopathy.17 Here, we confirm these results,
demonstrating a reduced interaction between the mitochon-
dria and the SR through the proximal ligation assay. The effect
of this was a reduced mitochondrial Ca2+ overload observed
during simulated I/R. The observations of no differences in
cytosolic Ca2+ handling between WT and DKO cardiomyo-
cytes but a reduced mitochondrial Ca2+ uptake in DKO cells
during hypoxia is consistent with inefficient tethering of
mitochondria to SR in the absence of Mfns. We propose that
the acute effects of ablating both cardiac Mfn1 andMfn2 would
be to uncouple the SR from mitochondria, thereby reducing
themitochondrial uptake of Ca2+ and preventingmitochondrial
Ca2+ overload during acute I/R injury. The reduced mitochon-
drial Ca2+ levels could also correlate with the reduced cardiac
output observed in DKO mice when assessed by echocardio-
graphy, as a result of impaired bioenergetics.
We also observed reduced endogenous mitochondrial
respiratory function in the DKO mice, at both complex
I and complex II. Inhibition of mitochondrial respiration
is well documented to be protective in the setting of I/R
Figure 5 Acute ablation of both cardiac Mfn1 and Mfn2 attenuated mitochondrial Ca2+ uptake during acute I/R injury. (a) There was no significant difference in cytosolic Ca2+
(measured by Fluo4 fluorescence) between the genotypes under baseline conditions, at the end of simulated ischemia and 25 and 45 min after simulated reperfusion, between
DKO and WT ventricular cardiomyocytes (two-way ANOVA P40.05, comparing genotypes across the I/R treatment). (b) Representative phase contrast and confocal Fluo4
images of WTand DKO cardiomyocytes taken at the end of simulated ischemia. (c) Mitochondrial Ca2+ handling during simulated ischemia-reperfusion was significantly different
between the two genotypes (two-way ANOVA between genotypes P= 0.002). Bonferroni post-test revealed a significant increase in WT mitochondrial Ca2+ during ischemia
(P40.01), with no differences in mitochondrial Ca2+ under baseline conditions, and 25 and 45 min after simulated reperfusion, between DKO andWT ventricular cardiomyocytes.
(d) Representative phase contrast and confocal Rhod2 images of WTand DKO cardiomyocytes taken at the end of simulated ischemia. (e) Treatment with 50 μM tBHQ (SERCA
inhibitor) stimulated a gradual increase in mitochondrial Ca2+ (measured by Rhod2 fluorescence) in WT cardiomyocytes, which peaked 45 min after initial administration. In DKO
myocytes, the increase in Rhod2 fluorescence stimulated by tBHQ was delayed, with a marginal increase after 60 min. A two-way ANOVA revealed a significant difference in
mitochondrial Ca2+ handling between the genotypes across the time points studied (P= 0.0004). (f) Representative phase contrast and confocal Rhod2 images of WTand DKO
cardiomyocytes taken after 45 min of tBHQ treatment. N= 4 mice/group. Error bars indicate S.E.M. and statistical analysis was performed by a two-way ANOVAwith a Bonferroni
post-test. **P≤ 0.001
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through a reduced oxygen consumption, and reduced ROS
production.31–35 Therefore, there appears to be two mechan-
isms that converge to reduce mitochondrial ROS production in
DKO cardiomyocytes during I/R, a reduced mitochondrial
Ca2+ overload and a reducedmitochondrial respiratory capacity.
We hypothesize that the 4 weeks of decreased Ca2+ transfer
from the SR to mitochondria contributed to the decrease in
respiratory capacity that we observed in the DKO mice.
Oxidative stress produced in response to acute I/R injury is
a critical inducer of MPTPopening and cardiomyocyte death at
Figure 6 Acute ablation of both cardiac Mfn1 and Mfn2 attenuated production of oxidative stress during acute I/R injury. (a) The increase in oxidative stress (measured by
H2DCFDA fluorescence) observed in WT cardiomyocytes during simulated ischemia and reperfusion was attenuated in DKO cardiomyocytes. There was a statistical difference in
oxidative stress handling between the two genotypes across the I/R protocol (Po0.001, two-way ANOVA), with further statistical significance at 25 min after simulated
reperfusion (Bonferroni post-test Po0.01). (b) Representative phase contrast and confocal H2DCFDA images of WT and DKO cardiomyocytes taken at the end of simulated
ischemia. (c) There was no difference in mitochondrial membrane potential (measured by 30 nM TMRM fluorescence) under baseline conditions, at the end of simulated ischemia
and 25 and 45 min after simulated reperfusion, between DKO and WT ventricular cardiomyocytes (two-way ANOVA with Bonferroni post-test). (d) Representative phase contrast
and confocal and TMRM images of WTand DKO cardiomyocytes taken at the end of simulated ischemia. N= 4 mice/group. Error bars are S.E.M and statistical analysis was
performed by a two-way ANOVA. *P≤ 0.05
Figure 7 Acute ablation of both cardiac Mfn1 and Mfn2 does not alter mitochondrial H2O2 emission. (a) Mitochondrial production of H2O2 was measured by Amplex Red.
Production of reactive oxygen species is similar between WT and DKO isolated mitochondrial at baseline. N= 3 triplicate runs of mitochondria isolated from nine mice.
(b) Mitochondrial production of H2O2 in the presence of 100 μM Ca
2+ and 1 μg/ml Antimycin A (to mimic I/R) was similar between WT and DKO isolated mitochondria.
N= 3 triplicate runs of mitochondria isolated from nine mice. (c) Expression of the mitochondrial Ca2+ uniporter is unaffected by KO of the Mfn proteins
Mfn1/Mfn2 deﬁciency protects against acute myocardial infarction
AR Hall et al
7
Cell Death and Disease
the onset of myocardial reperfusion. Preventing the production
of oxidative stress during acute I/R injury has been shown
to inhibit MPTP opening, attenuate cardiomyocyte death,
and reduce myocardial IS.36 In our study, we found that
H2O2 production from isolated mitochondria was no different
between genotypes, however, in isolated myocytes, the
increase in oxidative stress induced by acute I/R injury was
attenuated in hearts deficient in both Mfn1 and Mfn2. In these
hearts, the reduction in mitochondrial Ca2+ uptake would be
expected to impair mitochondrial respiratory function, the
results of which would be decreased production of oxidative
stress. Clearly, impaired mitochondrial respiratory function
would be expected to be detrimental in the long-term and
accounts for the cardiomyopathy observed in hearts lacking
Mitofusins37 – however, in the short term, it may be beneficial
in the response to acute I/R injury. It has been previously
documented that transient impairment of mitochondrial
respiration can protect the heart against acute I/R injury by
attenuating the production of oxidative stress.38
The opening of the MPTP in the first few minutes of
reperfusion uncouples mitochondrial oxidative phosphoryla-
tion resulting in ATP depletion and cardiomyocyte death, and
preventing MPTP at this time has been reported to attenuate
cell death and reduce myocardial IS. In our study, we found
that MPTP opening susceptibility was decreased in the DKO
cardiac mitochondria. Interestingly, cardiomyocytes with indi-
vidual knockouts of Mfn1 and Mfn2 have been reported to be
resistant to stress-induced MPTP opening.23,24 Whether this
is a direct or indirect effect upon the formation of the MPTP is
unknown, but is likely to contribute to the protective phenotype
observed here.
In summary, we have shown that acute ablation of both
cardiac Mfn1 and Mfn2 rendered the heart resistant to acute
myocardial infarction. We found that disruption to the interac-
tions between themitochondria and SR have an important role
in reducing mitochondrial Ca2+ overload, attenuating oxidative
stress, while dual KO of Mfn1 and Mfn2 inhibit MPTP opening,
contributing to this cardioprotective phenotype. Of interest, the
non-fusion pleiotropic effect of the Mitofusins in tethering the
SR to mitochondria appeared to be more important for cellular
protection against acute I/R injury than changes in mitochon-
drial morphology per se. It is important to note that although
the acute ablation of Mfn1 and Mfn2 appeared to be protective
against acute I/R injury, the long-term effects of ablating these
proteins would not be beneficial and has been shown to result
in a cardiomyopathy and sudden cardiac death.37 Therefore,
we would propose transient inhibition of the Mitofusins during
acute I/R injury to be a novel strategy for cardioprotection.
Materials and Methods
All animal experiments were conducted in accordance with the Animals (Scientific
Procedures) Act 1986 published by the UK Home Office and the Guide for the Care
and Use of Laboratory Animals published by the US National Institutes of Health
1996. All laboratory reagents were purchased from Sigma, Poole, UK, unless
otherwise stated. A more detailed methods section is found in the Supplementary
Methods section.
Genetic mice, myocardial infarction and cardiac phenotyping.
Cardiomyocyte-specific ablation of both Mfn1 and Mfn2 (DKO) was initiated in
mice aged 4–6 weeks using 5 days i.p. administration of tamoxifen (20 mg/kg/day)
(Myh6-MerCreMer inducible model).39 WT control mice were flx/flx littermates
injected with tamoxifen, but lacking the Cre-recombinase gene. All experiments
were performed in mice aged 8–10 weeks. The acute effects of cardiac-specific
ablation of both Mfn1 and Mfn2 on the susceptibility of acute I/R injury was
investigated using an in vivo model of acute myocardial infarction as described
previously.40 AAR and myocardial IS were determined and results presented as IS/
AAR%. Cardiac phenotyping was performed by transthoracic two-dimensional
echocardiography with Vivid 7 Dimension and 14 MHz probe (GE Healthcare,
Hatfield, UK) as previously described40 at baseline and 4 min following ISO
challenge (4 ng/g of body weight by intraperitoneal bolus).
Western blotting and electron microscopy. Isolated cardiac myocytes
were analyzed using standard western blotting techniques with the following
antibodies (Abcam, Cambridge, UK; unless stated otherwise) for Mfn1 (ab57602),
Mfn2 (ab124773), OPA1 (ab90857), Drp1 (#8570 Cell Signalling, Hitchin, UK),
OxPhos antibody cocktail (ab110413) and VDAC (ab15895). The acute effects of
cardiac-specific ablation of both Mfn1 and Mfn2 on mitochondrial morphology were
investigated using electron microscopy, as previously described.19 Mitochondrial
area was analyzed using ImageJ to tracing the outer mitochondrial membrane in 2D
EM images. Mitochondrial area was calculated accordingly.
Isolated cardiomyocyte studies. Ventricular cardiomyocytes were isolated
from WT and DKO hearts using Liberase digestion as described previously.41
Mitochondrial respiratory function was assessed in WT and DKO cardiomyocytes
using an Oxytherm (Hansatech, King’s Lynn, UK) in an adapted protocol.42 Cytosolic
and mitochondrial Ca2+, oxidative stress, and mitochondrial membrane potential
were measured under basal conditions and in response to acute I/R injury in WT
and DKO cardiomyocytes using Fluo4 (for cytosolic calcium), CM-H2DCFDA
(for oxidative stress), and TMRM (for mitochondrial membrane potential). Cells were
loaded with Rhod-2 and imaged prior to and during treatment with 50μM tert-
butylhydroquinone (tBHQ). For the PLA assay, isolated myocytes were fixed in 4%
PFA, permeabilized in PBS with 0.3% triton x100 for 15 min on ice prior to blocking
for 1 h at RT with PBS 5% BSA. Primary antibodies for VDAC (#4661, Cell
Signalling) and the RyR (Pan-RyR, #MA3-925, Thermo Scientific, Paisley, UK) were
incubated overnight (1:500). After washes in PBS, the proximal ligation assay
(Sigma, UK) was performed according to the manufacturer’s instructions. All images
were acquired using a Leica confocal microscope (Leica, Wetzlar, Germany),
ImageJ was used to assess fluorescence intensity (Fluo4, Rhod2, DCF, and TMRM)
and number of PLA interactions. Regions of interest were traced using the phase
image, and ROIs transferred to the fluorescent channel, where channel intensity
was measured, and normalized to cell area.
Isolated mitochondrial studies. Cardiac mitochondria were isolated from
WT and DKO mice as described previously43 through differential centrifugation.
Mitochondrial respiratory function was measured using an Oxytherm (Hansatech)
as previously described.44,45 Mitochondrial H2O2 emission was measured using
Amplex Red (Invitrogen, Paisley, UK) in isolated mitochondria (500 μg/ml) sus-
pended in Miro5 respiration buffer, according to the manufacturer’s instructions.
Complex I activity was stimulated by the addition of 5 mM Glutamate, 5 mM Malate,
and 1 mM Pyruvate, and complex II activity by the addition of 10 mM Succinate and
0.5 mM rotenone. Susceptibility to MPTP opening was investigated in isolated
cardiac mitochondria using a calcium-induced mitochondrial swelling assay, as
previously described45 with optical density measured by spectrophotometry
(FLUOstar Omega, BMG Labtech, Cary, NC, USA) for 20 min. Treatment with the
known MPTP inhibitor, cyclosporin-A (1.0 μmol/l), was used as a positive control.
Statistics. Results were analyzed using an unpaired t-test, Mann–Whitney
U test, a one-way analysis of variance followed by a Tukey post-test, or a two-way
analysis of variance where appropriate. Statistical significance was achieved when
Po0.05.
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